NCT02222194View on ClinicalTrials.gov

The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

May 30, 2017

Conditions
Non Small Cell Lung Cancer
Trial Locations (10)

3000

University Hospital Leuven, Leuven

8091

University Hospital, Division of Thoracic Surgery, Zurich

13125

ELK Berlin Chest Hospital, Berlin

13915

Aix-Marseille University & Hospitals System of Marseille (AP-HM), Marseille

56073

Katholisches Klinikum Koblenz, Koblenz

Katholisches Klinikum, Thoraxchirurgie, Koblenz

79106

Albert-Ludwigs-University Freiburg, Freiburg im Breisgau

81080

Istanbul University, Cerrahpasa Medical Faculty, Istanbul

08017

Hospital Universitari Mutua Terrassa, Barcelona

08036

Hospital Clinic; Barcelona University, Barcelona

All Listed Sponsors
lead

Johnny Moons

OTHER

NCT02222194 - The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer | Biotech Hunter | Biotech Hunter